Formestane: Difference between revisions

Jump to navigation Jump to search
m (Protected "Formestane": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
 
m (Bot: Automated text replacement (-{{SIB}} + & -{{EJ}} + & -{{EH}} + & -{{Editor Join}} + & -{{Editor Help}} +))
Line 1: Line 1:
{{Editor Help}}
 





Revision as of 02:50, 9 August 2012


Formestane
Clinical data
ATC code
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC19H26O3
Molar mass302.408 g/mol

Formestane belongs to a class of drugs known as aromatase inhibitors. It is used in the treatment of estrogen-receptor positive breast cancer in post-menopausal women. It is available as an intramuscular depot injection (Lentaron).

Formestane is often used to suppress estrogen production from anabolic steroids or prohormones.

Formestane has poor oral bioavailability and as such is no longer popular as many orally available aromatase inhibitors have been developed.

It is available as a supplement for bodybuilders in transdermal formulations.


Template:Sex hormones

Template:WikiDoc Sources